- Lufax Holding disclosed in January 2025 that its board proposed removing the company’s auditors and warned of a possible delay to its 2024 annual report, prompting multiple U.S. law firms to launch investigations into potential securities law violations.
- At the same time, Lufax’s March 2026 regulatory filing showed its authorized share capital structure unchanged at 10 billion shares, underscoring that governance and disclosure concerns, rather than capital changes, sit at the center of investor attention.
- We’ll now examine how the proposed auditor removal and related legal investigations shape Lufax’s investment narrative and perceived governance risk.
We've uncovered the 16 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
What Is Lufax Holding's Investment Narrative?
For anyone considering Lufax today, the core belief has to be that the business can work through both its operational reset and an increasingly complicated governance picture. The investment case used to hinge mainly on a low price-to-sales multiple and the possibility of earnings recovery from recent losses of about CN¥3,870.62 million. Now, the proposed removal of auditors, potential delay to the 2024 annual report and resulting securities law investigations sit front and center as short term catalysts and risks. These developments can affect market confidence, access to capital and how quickly any turnaround is recognized in reported numbers. The unchanged 10 billion authorized shares signal capital stability, but the mix of fresh leadership, heavy board turnover and legal scrutiny means sentiment may remain tightly tied to governance headlines.
However, the governance overhang and ongoing investigations are developments investors should be paying close attention to. Our valuation report here indicates Lufax Holding may be undervalued.Exploring Other Perspectives
Three fair value views from the Simply Wall St Community span roughly US$1.81 to US$2.99 per share, underscoring how far opinions can differ. Some see upside from today’s levels, while others appear more cautious given the recent governance concerns and legal overhang. It is worth weighing these contrasting expectations against the unresolved questions around auditor changes and board stability.
Explore 3 other fair value estimates on Lufax Holding - why the stock might be worth as much as 24% more than the current price!
Reach Your Own Conclusion
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Lufax Holding research is our analysis highlighting 2 key rewards that could impact your investment decision.
- Our free Lufax Holding research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Lufax Holding's overall financial health at a glance.
No Opportunity In Lufax Holding?
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
- The future of work is here. Discover the 28 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com